Sharekhan

BUY NOW Buy Pharmaids Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Pharmaids Pharmaceuticals Ltd

Wed 8/10/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Pharmaids Pharmaceuticals Ltd

Your Vote -

Buy

63.64%

Hold

27.27%

Sell

9.09%

63.64%

11 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Pharmaids Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    24 Sep 2025, 6:29PM Please find attached intimation regarding appointment of Secretarial Auditors.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    24 Sep 2025, 6:21PM Voting Results along with the Scrutiniser's Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    24 Sep 2025, 6:21PM Voting Results along with the Scrutiniser's Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    24 Sep 2025, 6:21PM Voting Results along with the Scrutiniser's Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM.

  • Pharmaids Pharma - Intimation Under Regulation 31A(10)(Ii) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati

    24 Sep 2025, 4:14PM Please find the attached intimation under Regulation 31A (10)(ii) of SEBI listing Regulations 2015.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    24 Sep 2025, 6:21PM Voting Results along with the Scrutiniser's Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    24 Sep 2025, 6:21PM Voting Results along with the Scrutiniser's Report of the 36th AGM of the Company held on 23rd September 2025 through VC/OAVM.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    23 Sep 2025, 3:27PM Outcome of the 36th Annual General Meeting of the Company held on September 23, 2025, i.e., Today at 11:30 a.m. through VC/OAVM.

  • Pharmaids Pharma - Reg. 34 (1) Annual Report.

    29 Aug 2025, 6:13PM Annual Report 2024-25

  • Pharmaids Pharma - Notice Of Convening The 36Th Annual General Meeting

    29 Aug 2025, 6:11PM The 36th Annual General Meeting is scheduled to be held on Tuesday, September 23, 2025 at 11.30 AM through VC/OAVM. Plesae find the Annual Report for

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    29 Aug 2025, 5:20PM Post open offer advertisement.

  • Pharmaids Pharma - Post Offer Advertisement

    29 Aug 2025, 12:09PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of the

  • Pharmaids Pharma - Announcement Under Reg 30(LODR) - Appointment Of Secretarial Auditor

    21 Aug 2025, 6:45PM Appointment of Secretarial Auditor.

  • Pharmaids Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 21, 2025.

    21 Aug 2025, 6:42PM Outcome of the Board Meeting held on August 21, 2025.

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    18 Aug 2025, 6:04PM Please find enclosed Scrutinizer's report along with the proceedings of the Meeting held by way of postal ballot through remote e voting process.

  • Pharmaids Pharma posts Q1 net loss of Rs 4.36 cr

    7 Aug 2025, 6:30PM The company reported standalone net loss during the quarter stood at Rs 4.36 crore as compared to net loss of Rs 1.62 crore in the previous year quart

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

    7 Aug 2025, 6:03PM Intimation under Regulation 30 of SEBI Listing Regulations, 2015 w.r.t resignation of Dr. S Prasad from the position of CEO of the Company.

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    7 Aug 2025, 6:00PM Enclosed disclosure under Regulation 30 of SEBI Listing Regulations, 2015.

  • Pharmaids Pharma - Unaudited Financial Results For The Quarter Ended June 30, 2025.

    7 Aug 2025, 5:55PM Unaudited Financial Results for the quarter ended June 30, 2025

  • Pharmaids Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Dated August 07, 2025.

    7 Aug 2025, 5:49PM Outcome of the Board meeting held today, i.e., August 07, 2025.

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    7 Aug 2025, 3:01PM Newspaper Publication of \Reminder Advertisement\ with regard to open offer to the public shareholders of the Company.

  • Pharmaids Pharma - Updates on Open Offer

    7 Aug 2025, 12:53PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of \Reminder Advertisement\ dated August 06, 2025 to the Pu

  • Pharmaids Pharma - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Con

    4 Aug 2025, 5:59PM Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to con

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    1 Aug 2025, 6:07PM Pre offer advertisement issued by Manager to the Open Offer on behalf of Dr. Shankarappa Nagaraja Vinaya Babu (\Acquirer\) along with Tumkur Trade Cen

  • Pharmaids Pharma - Updates on Open Offer

    1 Aug 2025, 12:33PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Offer Opening Public Announcement under Regulations 18(7

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    30 Jul 2025, 4:08PM Newspaper publication of recommendation of Committee of Independent Directors published on Wednesday, 30th July 2025.

  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    25 Jul 2025, 1:40PM Attached herewith Letter of Offer dated July 23, 2025 received by the Company.

  • Pharmaids Pharma - Letter of Offer

    25 Jul 2025, 11:07AM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Letter of Offer (\LOF\) for the attention of the Public

  • Pharmaids Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    21 Jul 2025, 12:31PM As of June 2025, 5.14% is owned by Indian Promoters and 94.86% by Public. <p align=justify> Top five Promoters holding highest number of shares of Pha

  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    14 Jul 2025, 4:47PM Postal Ballot Notice dated July 04, 2025
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Pharmaids Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 103.1888 83.5609 22.4252 8.6715 8.5264
Liabilities 103.1888 83.5609 22.4252 8.6715 8.5264
Equity 35.2678 35.2678 21.4438 10.2688 10.2688
Gross Profit -7.2573 -6.3711 -9.8862 0.137 0.1069
Net Profit -7.2792 -4.9498 -7.5556 0.1451 0.0933
Cash From Operating Activities -7.7243 -3.4432 -4.0193 -0.2593 0.4053
NPM(%) -310.95 -17805.03 0 3.68 1.09
Revenue 2.3409 0.0278 0 3.9392 8.551
Expenses 9.5982 6.3989 9.8862 3.8021 8.444
ROE(%) -10.83 -7.37 -11.25 0.21 0.13

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Pharmaids Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.60 3.47 72.03 28.18 301.39 0.63
Lotus Eye Hospital and Institute Ltd 121.15 0.54 387.81 102.69 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.20 0.33 0.00 213.22 -39.50 0.00
Astec Lifesciences Ltd 782.00 -1.46 0.00 96.84 -604.77 0.00

Company Info

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

Read More

Parent Organisation

Pharmaids Pharmaceuticals Ltd.

Founded

01/03/1989

Managing Director

NSE Symbol

FAQ

The current price of Pharmaids Pharmaceuticals Ltd is

The 52-week high for Pharmaids Pharmaceuticals Ltd is

The market capitalization of Pharmaids Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Pharmaids Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Pharmaids Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Pharmaids Pharmaceuticals Ltd shares.

The CEO of Pharmaids Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT